# Fifth Third Bancorp: overview

FITB · NYSE · CIK 35527 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fitb.md) · [Financials](/companies/fitb/financials.md) · [Filings](/companies/fitb/filings.md) · [Insiders](/companies/fitb/insiders.md)

Latest reported revenue: [$161.0m](/filings/0000035527-24-000249.md) for Q3 FY2024, three months to 2024-09-30, from the 10-Q filed Nov 5, 2024 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0000035527-24-000249).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [161](/filings/0000035527-24-000249.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [355.9%](/filings/0000035527-25-000212.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.78](/filings/0000035527-25-000212.md) | not reported | [0.71](/filings/0000035527-26-000182.md) | [0.88](/filings/0000035527-26-000202.md) | [0.91](/filings/0000035527-25-000212.md) | not reported | [0.15](/filings/0000035527-26-000182.md) | [0.83](/filings/0000035527-26-000202.md) |
| Free cash flow | $m | [1,747 d](/filings/0000035527-25-000212.md) | [(246) d](/filings/0000035527-26-000124.md) | [1,116](/filings/0000035527-26-000182.md) | [1,163 d](/filings/0000035527-26-000202.md) | [886 d](/filings/0000035527-25-000212.md) | [765 d](/filings/0000035527-26-000124.md) | [(1,252)](/filings/0000035527-26-000182.md) | [2,622 d](/filings/0000035527-26-000202.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [600](/filings/0000035527-24-000088.md) | [589](/filings/0000035527-24-000088.md) | [577](/filings/0000035527-24-000088.md) | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [461.7%](/filings/0000035527-24-000088.md) | [415.3%](/filings/0000035527-25-000079.md) | [407.1%](/filings/0000035527-26-000124.md) | not reported | not reported |
| Diluted EPS | $ per share | [3.73](/filings/0000035527-24-000088.md) | [3.35](/filings/0000035527-25-000079.md) | [3.22](/filings/0000035527-26-000124.md) | [3.14](/filings/0000035527-26-000124.md) | [3.53](/filings/0000035527-26-000124.md) |
| Free cash flow | $m | [2,395](/filings/0000035527-24-000088.md) | [6,080](/filings/0000035527-25-000079.md) | [4,018](/filings/0000035527-26-000124.md) | [2,410](/filings/0000035527-26-000124.md) | [3,930](/filings/0000035527-26-000124.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fitb/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 4 | $53.255 | $213.02 | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 910 | $53.245 | $48.5k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 300 | $53.235 | $16.0k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 372 | $53.23 | $19.8k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 500 | $53.225 | $26.6k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 200 | $53.22 | $10.6k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 200 | $53.215 | $10.6k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 200 | $53.21 | $10.6k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 300 | $53.19 | $16.0k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 200 | $53.185 | $10.6k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 200 | $53.18 | $10.6k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 3,032 | $53.175 | $161.2k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 1,100 | $53.165 | $58.5k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 791 | $53.155 | $42.0k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 2,800 | $53.145 | $148.8k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 600 | $53.14 | $31.9k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 300 | $53.135 | $15.9k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 2,700 | $53.125 | $143.4k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 400 | $53.115 | $21.2k | [Form 4](/filings/0000035527-26-000231.md) |
| 2026-10-26 | [Schramm Jude](/insiders/1736276.md) | EVP & CIO, Officer | Sale (S) | 900 | $53.095 | $47.8k | [Form 4](/filings/0000035527-26-000231.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $4.67bn | 82,862,442 |  | Added +2,108,993 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.34bn | 59,173,580 |  | Added +743,040 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.69bn | 47,639,510 |  | Added +605,950 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.36bn | 41,617,059 |  | Added +1,033,751 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $2.21bn | 39,246,596 |  | Added +172,057 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $1.70bn | 29,970,128 |  | Reduced −237,949 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $1.66bn | 29,374,537 |  | Added +4,598,296 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $1.66bn | 29,371,774 |  | Added +2,893,308 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $1.45bn | 25,767,990 |  | Reduced −409,945 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.37bn | 24,484,438 |  | Reduced −445,271 |

## Recent filings

[All 3,100 filings](/companies/fitb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 06:30 ET | [8-K](/filings/0000035527-26-000229.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000035527-26-000229 |
| 2026-09-24 | 08:29 ET | [8-K](/filings/0000035527-26-000224.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000035527-26-000224 |
| 2026-09-23 | 16:28 ET | [8-K](/filings/0000035527-26-000222.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000035527-26-000222 |
| 2026-09-14 | 17:10 ET | [8-K](/filings/0000035527-26-000219.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000035527-26-000219 |
| 2026-08-21 | 08:11 ET | [8-K](/filings/0000035527-26-000209.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000035527-26-000209 |
| 2026-08-04 | 16:18 ET | [10-Q](/filings/0000035527-26-000202.md) | Quarterly report, period 2026-06-30 | 0000035527-26-000202 |
| 2026-07-30 | 17:09 ET | [8-K](/filings/0000035527-26-000197.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000035527-26-000197 |
| 2026-07-17 | 06:30 ET | [8-K](/filings/0000035527-26-000193.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000035527-26-000193 |
| 2026-06-10 | 16:34 ET | [8-K](/filings/0001193125-26-265928.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-265928 |
| 2026-06-09 | 16:30 ET | [8-K](/filings/0000035527-26-000190.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000035527-26-000190 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000035527-26-000124.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 35527
- Tickers: FITB, FITB-PA, FITB-PI, FITB-PK, FITB-PM
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: OH
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Nov 2, 2026, 16:31 ET. No prices; not investment advice.